IP Library Granted Patent US 7,323,192
Granted Patent B2
US 7,323,192 · App. 09/966,493 · Granted Jan 29, 2008

Immediate release tablet

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,323,192
App. No.
09/966,493
Granted
Jan 29, 2008
Kind
B2
Abstract

An immediate release tablet is provided. The tablet comprises at least 60 weight % of an active ingredient and powdered wax having a melting point greater than about 90° C. The tablet may advantageously be produced by direct compression. Although the wax is hydrophobic, the tablet has excellent disintegration.

Claims (9)

1. A swallowable immediate release tablet consisting essentially of at least 60 weight % of acetaminophen, from about 1 to about 10 weight % of a powdered wax having an melting point greater than about 90° C. and a particle size in the range of about 5 to about 100 microns, and less than about 25 weight % of a disintegrant, wherein the acetaminophen is released from the swallowable immediate release tablet by 30 minutes in pH 5.8 buffer.

2. The tablet of claim 1 , wherein the wax is selected from the group consisting of linear hydrocarbons, microcrystalline wax, and mixtures thereof.

3. The tablet of claim 1 prepared by direct compression.

4. The tablet of claim 1 which is substantially free of water-soluble, non-saccharide polymeric binders.

5. The tablet of claim 1 , which is substantially free of hydrated polymers.

6. The tablet of claim 1 further comprising an excipient selected from the group consisting of flow aids, and lubricants.

7. A swallowable immediate release tablet consisting essentially of at least 60 weight percent of acetaminophen, from about 1 to about 10 weight % of a powdered wax having a particle size in the range of about 5 to about 100 microns that is selected from the group consisting of shellac wax, paraffin-type waxes, polyethylene glycol, and mixtures thereof, and less than about 25 weight % of a disintegrant, wherein said swallowable immediate release tablet is prepared by direct compression, and the acetaminophen is released from the swallowable immediate release tablet by 30 minutes in pH 5.8 buffer.

8. A swallowable immediate release tablet consisting essentially of at least 60 weight percent of acetaminophen, from about 1 to about 10 weight % of a powdered wax having a particle size in the range of about 5 to about 100 microns that is selected from the group consisting of shellac wax, paraffin-type waxes, polyethylene glycol, and mixtures thereof, and less than about 25 weight % of a disintegrant, wherein said swallowable immediate release tablet is substantially free of water-soluble, non-saccharide polymeric binders, and the acetaminophen is released from the swallowable immediate release tablet by 30 minutes in pH 5.8 buffer.

9. A swallowable immediate release tablet consisting essentially of at least 60 weight percent of acetaminophen, from about 1 to about 10 weight % of a powdered wax having a particle size in the range of about 5 to about 100 microns that is selected from the group consisting of shellac wax, paraffin-type waxes, polyethylene glycol, and mixtures thereof, and less than about 25 weight % of a disintegrant, wherein said swallowable immediate release tablet is substantially free of hydrated polymers, and the acetaminophen is released from the swallowable immediate release tablet by 30 minutes in pH 5.8 buffer.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Jul 2, 2015
From: MCNEIL-PPC, INC.; JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 036049/0254 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2002
From: LUBER, JOSEPH; BUNICK, FRANK J.
To: MCNEIL-PPC, INC.
Reel/Frame 012347/0288 →